These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
908 related articles for article (PubMed ID: 23482734)
1. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734 [TBL] [Abstract][Full Text] [Related]
2. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software. Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006 [TBL] [Abstract][Full Text] [Related]
3. Drug-drug interactions in a cohort of hospitalized elderly patients. Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765 [TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of drug-drug interactions in hospitalized dermatology patients. Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216 [TBL] [Abstract][Full Text] [Related]
5. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients. Rosas-Carrasco O; García-Peña C; Sánchez-García S; Vargas-Alarcón G; Gutiérrez-Robledo LM; Juárez-Cedillo T Rev Invest Clin; 2011; 63(6):564-73. PubMed ID: 23650669 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians. Kerr KP; Mate KE; Magin PJ; Marley J; Stocks NP; Disler P; Pond CD J Clin Pharm Ther; 2014 Aug; 39(4):383-9. PubMed ID: 24702306 [TBL] [Abstract][Full Text] [Related]
7. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Cannon KT; Choi MM; Zuniga MA Am J Geriatr Pharmacother; 2006 Jun; 4(2):134-43. PubMed ID: 16860260 [TBL] [Abstract][Full Text] [Related]
8. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 9: Interactions Mediated by Drug-metabolizing Cytochrome P450 Enzymes. Preskorn SH J Psychiatr Pract; 2020 Mar; 26(2):126-134. PubMed ID: 32134885 [TBL] [Abstract][Full Text] [Related]
9. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. Nobili A; Pasina L; Tettamanti M; Lucca U; Riva E; Marzona I; Monesi L; Cucchiani R; Bortolotti A; Fortino I; Merlino L; Walter Locatelli G; Giuliani G J Clin Pharm Ther; 2009 Aug; 34(4):377-86. PubMed ID: 19583670 [TBL] [Abstract][Full Text] [Related]
10. Potentially inappropriate prescribing to hospitalised patients. Radosević N; Gantumur M; Vlahović-Palcevski V Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):733-7. PubMed ID: 18050360 [TBL] [Abstract][Full Text] [Related]
11. [Drug-drug interactions in multicentre polypathological polymedicated patients]. Galindo-Ocaña J; Gil-Navarro MV; García-Morillo JS; Bernabeu-Wittel M; Ollero-Baturone M; Ortiz-Camuñez MA Rev Clin Esp; 2010 Jun; 210(6):270-8. PubMed ID: 20434722 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study. Hughes JE; Russo V; Walsh C; Menditto E; Bennett K; Cahir C Drugs Aging; 2021 Nov; 38(11):1025-1037. PubMed ID: 34632551 [TBL] [Abstract][Full Text] [Related]
13. Quantifying the impact of drug-drug interactions associated with opioids. Pergolizzi JV Am J Manag Care; 2011 Sep; 17 Suppl 11():S288-92. PubMed ID: 21999761 [TBL] [Abstract][Full Text] [Related]
14. Incidence and contributors to potential drug-drug interactions in hospitalized patients. Reimche L; Forster AJ; van Walraven C J Clin Pharmacol; 2011 Jul; 51(7):1043-50. PubMed ID: 20926752 [TBL] [Abstract][Full Text] [Related]
16. Review of prescription medications in home-based older adults with stroke: a pilot study. Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. Gagne JJ; Maio V; Rabinowitz C J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study. Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926 [TBL] [Abstract][Full Text] [Related]
19. Drug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel? Corsini A; Ceska R Curr Med Res Opin; 2011 Aug; 27(8):1551-62. PubMed ID: 21682551 [TBL] [Abstract][Full Text] [Related]
20. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. Solberg LI; Hurley JS; Roberts MH; Nelson WW; Frost FJ; Crain AL; Gunter MJ; Young LR Am J Manag Care; 2004 Nov; 10(11 Pt 1):753-9. PubMed ID: 15623265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]